Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines

BACKGROUND: OnabotulinumtoxinA 20 U reduces glabellar line (GL) severity at maximum frown for approximately 3 to 4 months. Small studies have suggested that >20-U doses may increase the efficacy and duration of response for GLs. OBJECTIVES: The aim of this study was to evaluate safety, pharmacody...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, John H, Maas, Corey, Palm, Melanie D, Lain, Edward, Glaser, Dee Anna, Bruce, Suzanne, Yoelin, Steven, Cox, Sue Ellen, Fagien, Steven, Sangha, Sara, Maltman, John, Lei, Xiaofang, Brin, Mitchell F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cosmetic Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558451/
https://www.ncbi.nlm.nih.gov/pubmed/35704394
http://dx.doi.org/10.1093/asj/sjac157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558451/
https://www.ncbi.nlm.nih.gov/pubmed/35704394
http://dx.doi.org/10.1093/asj/sjac157

Ejemplares similares